Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The fourth volume of this series features 5 chapters that cover the following topics:
- An overview of the incidence of neuraminadase resistance in influenza viruses in the Americas from 2004 to 2014
- Phenothiazines and derivative compounds for treating Trypanosoma cruzi infections
- New antibacterial drug targets such as polysaccharide deacetylases
- Improvements in aminoglycoside synthesis and biological activity (including RNA targeting)
- A review of new chemotherapeutic agents against common infections.
Loading...
Loading...
